Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05203406

The Cardio-Sarcopenia Study

The use of surrogate markers such as body mass index (BMI) as a target outcome of physical activity may not be appropriate in older adults who are at risk of muscle sarcopenia. In the presence of sarcopenia, reductions in body weight may lead to lower BMI values. We have previously found deleterious changes in cardiac structure and function among sarcopenic older adults, raising a possible biological syndrome of 'cardio-sarcopenia'. In this study, we will investigate the impact of physical activity on temporal changes in cardiac and skeletal muscle , and BMI, over six- to twelve month period, on older adults with this syndrome. By targeting the cardio-sarcopenic phenotype as a modifiable risk factor that may be altered by physical activity, the results will provide new knowledge into retarding deleterious consequences of cardiovascular ageing. This new target challenges the paradigm of using BMI as an anthropometric marker in health prevention. If proven, this will dramatically change primary prevention targets among older adults, justifying the use of cardio-sarcopenia as a rational anthropometric target.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

About this study

This study builds upon our group's work where we characterized cardiovascular and skeletal muscle structure and function of community-based older adults. In this proposal, we will identify n=100 participants with cardio-sarcopenia phenotype. Comparing between participants with baseline low versus high levels of physical activity, we will investigate temporal changes in their cardiovascular, skeletal muscle, biomarkers and BMI data, over a six- to twelve month period. Physical activity will include subjective self-reported physical activities and objective measures of aerobic capacity. Their physical activity levels will be verified bi-monthly via physical activity and cardiac health application that measures these markers. Pertinent fluctuations in diet, lifestyle, risk factors and biomarkers will also be recorded.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • >=21 years of age

Exclusion criteria

  • Unable to provide written informed consent to participate in the study.

Treatment and study plan

Primary outcomes

  1. Changes in cardio-sarcopenia

    Time frame: Six to twelve months

    To compare differences in skeletal muscle (structure and function) and CV imaging markers, between older adults with low versus high physical activity levels, over time, at baseline and at six- to twelve months

Secondary outcomes

  1. Changes in body mass index (BMI)

    Time frame: Six to Twelve months

    To study rates of changes in body mass index in relation to changes in cardio-sarcopenia.

Other outcomes

  1. Changes in cardiac function as assessed by personalized digital health application.

    Time frame: Six to Twelve month

    To test feasibility and utility of using cardiac health application to input markers of physical activity, deriving automated feedback about cardiac function.

Sponsors and collaborators

Lead sponsor

National Heart Centre Singapore

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2051
First posted
Jan 24, 2022
Registry last updated
Jun 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.